Carvacrol’un Ratlarda Böbrek İskemi Reperüzyon Hasarı Üzerine Koruyucu Etkileri

Amaç: Ratlarda böbrek iskemi reperfüzyonu hasarı üzerine Carvacrol (CARV) 'ün koruyucu etkilerini araştırmaktır. Yöntemler: Ağırlıkları 200-250 gr arasında değişen, 30 adet erkek Wistar Albino ratlar rastgele grublara ayrıldı. 50 mg/kg ketamin ve 3mg/ kg ksilazin (periton içi) ile anestezi sağlandı. Renal arter trombozunu önlemek için 100 İU/kg heparin (periton içi) uygulamasından sonra orta hat kesi ile tüm ratlara sağ nefrektomi yapıldı. Grup I (Sham): Sağ nefrektomiyi takiben 6 saat sonra sol nefrektomi yapıldı. Grup II (I/R): Sağ nefrektomiyi takiben sol böbrek, 60 dakika iskemi ve 6 saat reperfüzyonda bırakıldı. Grup III(I/R+CARV): Grup II de uygulanan işleme ek olarak, iskemi ve reperfüzyondan hemen önce toplam 2 kez 35mg/kg periton içine Carvacrol verildi. Altı saatlik reperfüzyonu takiben ratların tamamı kardiak ponksiyonla yüksek miktarda kan alınarak sakrifiye edildi ve sol nefrektomi yapıldı. Alınan serum ve dokulardaki proiflamatuar sitokinler, oksidatif stres parametreleri çalışıldı ve histopatolojik inceleme yapılarak gruplar arasında karşılaştırma yapıldı. Bulgular: Böbrek fonksiyon göstergesi olan Serum BUN ve kreatinin düzeyleri, I/R grubunda Sham grubuna kıyasla yükselmiş ve iskeminin gerçekleştiğini göstermektedir(p

Protective Effects of Carvacrol on Renal Ischemia Reperfusion Damage in Rat

Objective: The aim of this study was to investigate the protective effect of Carvacrol (CARV) on renal ischemia reperfusion (I/R) injury in rats. Method: 30 male Wistar Albino rats weighing 200-250 gr were divided into random groups. Anesthesia was achieved with 50 mg / kg ketamine and 3 mg/kg xylazine (intraperitoneal). Right nephrectomy was performed to all rats by midline incision after 100 IU/kg heparin (intraperitoneal) application to prevent renal artery thrombosis. Subsequently, the left renal artery was clamped, created ischemia for 60 minutes. Group I (Sham): Left nephrectomy was performed six hours after right nephrectomy. Group II (I/R): Following right nephrectomy, left kidney was left for 60 minutes for ischemia and 6 hours for reperfusion. G roup I II ( I/R+CARV): In addition to t he p rocedure performed i n group I I, C arvacrol w as g iven 2 t imes 35 mg/ kg intraperitoneally just before ischemia and reperfusion. After six hours of reperfusion, all rats were sacrificed by cardiac puncture with a high volume of blood and left nephrectomy was performed. The parameters of oxidative stress and proinflammatory cytokines in the serum and tissues were analyzed and histopathological examination was performed to compare the groups. Results: Serum BUN and creatinine levels, which are indicators of kidney function, increased in Group II compared to Group I, which shows that ischemia occurred. (p

___

  • 1. Himmelfarb J, Ikizler TA. Acute kidney injury: Changing lexicography, definitions, and epidemiology. Kidney Int. 2007; 71: 971-6.
  • 2. Kara AV, Tanrikulu S, Aydın E, et al. Evaluation of the effect of red cell distribution width on the development of acute renal failure in patients with sepsis. Dicle Med J. 2017; 44: 191-8
  • 3. Ozturk H, Cetinkaya A, Duzcu SE, et al. Carvacrol attenuates histopathogic and functional impairments induced by bilateral renal ischemia/reperfusion in rats. Biomed Pharmacother. 2018; 98: 656-61.
  • 4. Salvadori M, Rosso G, Bertoni E. Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment. World J Transplant. 2015; 5: 52-67.
  • 5. Weight SC, Bell PR, Nicholson ML. Renal ischaemia-reperfusion injury. Br J Surg. 1996; 83: 162-70.
  • 6. Hong X, Zhao X, Wang G, et al. Luteolin treatment protects against renal ıschemia-reperfusion ınjury in rats. Mediators Inflamm. 2017; 2017: 9783893.
  • 7. Cho JH, Choi SY, Ryu HM, et al. Fimasartan attenuates renal ischemia-reperfusion injury by modulating inflammation-related apoptosis. Korean J Physiol Pharmacol. 2018; 22: 661-70.
  • 8. Akdere H, Tastekin E, Mericliler M, et al. The protective effects of Ginkgo biloba EGb761 extract against renal ischemia-reperfusion injury in rats. Eur Rev Med Pharmacol Sci. 2014; 18: 2936-41.
  • 9. Lima Mda S, Quintans-Junior LJ, de Santana WA, et al. Anti-inflammatory effects of carvacrol: evidence for a key role of interleukin-10. Eur J Pharmacol. 2013; 699: 112-17.
  • 10. Esterbauer H, Zollner H. Methods for determination of aldehydic lipid peroxidation products. Free Radic Biol Med. 1989; 7: 197-203.
  • 11. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005; 38: 1103-11.
  • 12. Chatterjee PK. Novel pharmacological approaches to the treatment of renal ischemiareperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol. 2007; 376: 1-43.
  • 13. Kellum JA, Unruh ML, Murugan R. Acute kidney injury. BMJ Clin Evid. 2011; 28: 2001.
  • 14. Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment. J Renal Inj Prev. 2015; 4: 20-7.
  • 15. Edelstein CL. Biomarkers of acute kidney injury. Adv Chronic Kidney Dis. 2008; 15: 222-34.
  • 16. Hopkins SJ. The pathophysiological role of cytokines. Leg Med. 2003; 5: 45-57.
  • 17. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol. 2008; 109: 102-7.
  • 18. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol. 2003; 14: 2199-210.
  • 19. Bonventre JV, Zuk A. Ischemic acute renal failure: An inflammatory disease? Kidney Int. 2004; 66: 480-5.
  • 20. Rah DK, Han DW, Baek HS, et al. Protection of rabbit kidney from ischemia/reperfusion injury by green tea polyphenol pretreatment. Arch Pharm Res. 2007; 30: 1447-54.
  • 21. Korkmaz A, Kolankaya D. The protective effects of ascorbic acid against renal ischemia-reperfusion injury in male rats. Ren Fail 2009; 31: 36-43.
  • 22. Kontogiannis J, Burns KD. Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol. 1998; 274: 79-90.
  • 23. Choucry M A, K halil M NA, E l A wdan S A. Protective action of Crateva nurvala Buch. Ham extracts against renal ischaemia reperfusion injury in rats via antioxidant and anti-inflammatory activities. J Ethnopharmacol. 2018; 214: 47-57.
  • 24. Iyer S S, C heng G . R ole o f i nterleukin 1 0 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012; 32: 23-63.
  • 25. de Waal Malefyt R, Abrams J, Bennett B, et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991; 174: 1209-20.
  • 26. Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicology. 2003; 189: 41-54.
  • 27. Okur MH, Arslan S, Aydogdu B, et al. Protective effect of cordycepin on experimental testicular ıschemia / reperfusion ınjury in rats. J Invest Surg. 2018; 31: 1-8.
  • 28. Gokce A, Oktar S, Koc A, et al. Protective effect of thymoquinone in experimental testicular torsion. Urol Int. 2010; 85: 461-5.
  • 29. Ates M, Köksal MH, Celayir MF, et al. Prophylactic and therapeutic effect of ginko biloba extract (Egb761) on mortality of intestinal deep ischemiareperfusion model in rats. Dicle Med J. 2010; 37: 199-203.
Dicle Tıp Dergisi-Cover
  • ISSN: 1300-2945
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1963
  • Yayıncı: Cahfer GÜLOĞLU
Sayıdaki Diğer Makaleler

Evaluation of Heart Rate, Work Rate and O2 Uptake Relationships During Constant Load Exercise Test Work Load at the Anaerobic Threshold in Healthy Male

Seda UGRAS, Oguz OZCELIK

Psychological Stress of Healthcare Workers Caused by the COVID-19 Pandemic

Gülşen YALCIN, Bahattin SAYINBATUR, Eyaz KARAY, Merve KARAKAS

Investigation of the Association between Bispectral index and Body Temperature during Abdominal Surgery; An Observational Study

Çi̇ğdem AKYOL BEYOĞLU, Ceylan SAYGILI, Mustafa DILEK, Guniz Meyanci KOKSAL

Treatment management of giant retroperitoneal localized liposarcoma

Hüseyin BİLGE, Ömer BAŞOL, Mehmet RENÇBER, Gizem YAMAN, Abdullah OĞUZ

The Most Important Factors in Prognosis Of Obstetric Patients with Disseminated Intravascular Coagulation: A Tertiary Center Study

Abdulkadir TURGUT, Nurullah PEKER, Elif AGACAYAK, Gamze AKIN EVSEN, Edip AYDIN, Mehmet Sait ICEN, Talip KARACOR, FATİH MEHMET FINDIK, Feyzi CELIK, Emre DIRICAN, Talip GUL

Bilgisayarlı Tomografi Eşliğinde PerkütanTranstorasik Akciğer Biopsilerinin Değerlendirilmesi: Tek Merkez Deneyimi

Muhammed Akif DENIZ, Zelal Taş DENIZ, SALİH HATTAPOĞLU, Mehmet Guli ÇETINCAKMAK, Osman KURT

Multipl Skleroz’de Yaşam Kalitesi: Depresif Bulgular Fiziksel Özürlülük Kadar Etkili midir?

Mesrure KÖSEOGLU, R. Gökçen GÖZÜBATIK ÇELİK, Mesude TÜTÜNCÜ, Çelikkol Bahar ERBAŞ

Frequency of Brucellosis and Hepatitis B Virus Seropositivity in Patients with Chronic Lymphocytic Leukemia

Omer EKINCI, Senar EBINC, Ali DOGAN, Cengiz DEMIR

Sağlık Çalışanlarının Kızamık, Kızamıkçık, Kabakulak ve Suçiçeği Geçirme ve Aşılanma Durumlarının Değerlendirilmesi (Ülke Geneli Çok Merkezli Çalışma)

Handan ALAY, Ayşe Ferdane OGUZONCUL, Ayşe TORUN, Gülnur KUL, Selma TOSUN, Fethiye AKGUL, Emine KUCUKATES, Raziye GÜMÜŞTAKIM, sevil alkan çeviker, Fatma KESMES CAN, Asiye Bahar KACMAZ, Hüseyin Aytaç ERDEM, Ebru DEMİRAY GÜRBÜZ, Uğur KOSTAKOGLU, Hilal BÖLÜKBAŞI, Nuray KASAR, Emre GÜVEN, Serap PAMUKÇUOĞLU

Parkinson's Disease Profile – A 17-Year Patient Analysis

Ahmet ADIGUZEL, Unal OZTURK, Sibel ALTINAYAR